drugset / Trial / NCT06701812
Digoxin Medulloblastoma Study
Phase 2
Recruiting
23 enrolled
H. Lee Moffitt Cancer Center and Research Institute
National Pediatric Cancer Foundation · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy of digoxin in treating relapsed non-SHH, non-WNT medulloblastoma in pediatric and young adult patients.
Timeline
- Start
- 2026-01-15
- Primary completion
- 2027-02
- Completion
- 2027-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Digoxin | Other / unclassified | 2.5 ug/kg | Oral |
| Subject | Digoxin | Other / unclassified | 10 ug/kg | Oral |